References
- Antoine DJ, Dear JW, Starkey-Lewis P et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 58(2), 777–787 (2013).
- Acetadote®, Package insert. Cumberland Pharmaceuticals, TN, USA.
- Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J. Toxicol. Clin. Toxicol. 40(1), 3–20 (2002).
- Rumack BH. Acetaminophen overdose in children and adolescents. Pediatr. Clin. North Am. 33(3), 691–701 (1986).
- Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N. Engl. J. Med. 319(24), 1557–1562 (1988).
- Heard KJ. Acetylcysteine for acetaminophen poisoning. N. Engl. J. Med. 359(3), 285–292 (2008).
- Fontana RJ. Acute liver failure including acetaminophen overdose. Med. Clin. North Am. 92(4), 761–794, viii (2008).
- Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44(1), 27–33 (2006).
- Starkey Lewis PJ, Dear J, Platt V et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 54(5), 1767–1776 (2011).
- James LP, Simon MT, Capparelli EV et al. Pharmacokinetic analysis of acetaminophen protein adducts in adults with acute liver failure. Clin. Pharmacol. Ther. 81, 2 (2007).